Published in FEBS Lett on June 07, 1982
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest (1983) 3.41
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab (1988) 7.09
Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet (1982) 6.40
Epidemic influenza and vitamin D. Epidemiol Infect (2006) 5.32
Redefining vitamin D insufficiency. Lancet (1998) 5.26
Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol (1979) 4.86
Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest (1985) 3.59
Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest (1983) 3.41
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science (1980) 3.06
Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol (1984) 2.84
Ultraviolet B and blood pressure. Lancet (1998) 2.83
Control of 25-hydroxycholecalciferol metabolism by parathyroid glands. Proc Natl Acad Sci U S A (1972) 2.77
Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med (1985) 2.57
1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science (1972) 2.50
Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry (1971) 2.50
Biogenesis of intestinal plasma membrane: posttranslational route and cleavage of sucrase-isomaltase. Proc Natl Acad Sci U S A (1979) 2.45
1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest (1984) 2.39
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr (1994) 2.22
Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science (1981) 2.20
A new chromatographic system for vitamin D3 and its metabolites: resoluation of a new vitamin D3 metabolite. J Lipid Res (1971) 2.12
Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07
Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line. J Cell Biol (1990) 2.02
Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases. J Biol Chem (1982) 1.93
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology (2000) 1.93
Hypervitaminosis D associated with drinking milk. N Engl J Med (1992) 1.90
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science (1982) 1.80
1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol (1985) 1.79
Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine. Proc Natl Acad Sci U S A (1971) 1.78
Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem (1990) 1.76
Microtubular organization and its involvement in the biogenetic pathways of plasma membrane proteins in Caco-2 intestinal epithelial cells. J Cell Biol (1991) 1.74
1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet (1979) 1.71
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev (1998) 1.69
Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun (2001) 1.69
21,25-dihydroxycholecalciferol. A metabolite of vitamin D3 preferentially active on bone. Biochemistry (1970) 1.65
An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr (1990) 1.65
Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology (1999) 1.64
The response of intestinal calcium transport to 25-hydroxy and 1,25-dihydroxy vitamin D in nephrectomized rats. Endocrinology (1972) 1.63
Race/ethnic differences in bone mineral density in men. Osteoporos Int (2007) 1.63
Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D made in the kidney. Biochemistry (1972) 1.62
25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet (2001) 1.61
Cell-specific signal transduction of parathyroid hormone (PTH)-related protein through stably expressed recombinant PTH/PTHrP receptors in vascular smooth muscle cells. Endocrinology (1996) 1.61
Establishment and characterizaton of intestinal epithelial cell cultures. Methods Cell Biol (1980) 1.59
1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52
Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med (2001) 1.51
Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1973) 1.50
A long-term follow-up study of diabetic patients in Osaka, Japan: mortality and causes of death. Tohoku J Exp Med (1983) 1.50
Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci U S A (1978) 1.49
Response of intestinal calcium transport and bone calcium mobilization to 1,25-dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology (1974) 1.48
Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States) Cancer Causes Control (1998) 1.46
Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial. Br J Dermatol (2013) 1.46
Modulation of transcytotic and direct targeting pathways in a polarized thyroid cell line. EMBO J (1992) 1.44
Monoclonal antibodies to sucrase/isomaltase: probes for the study of postnatal development and biogenesis of the intestinal microvillus membrane. Proc Natl Acad Sci U S A (1980) 1.44
Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro (1984) 1.43
Exogenous calciferol (vitamin D) and vitamin D endocrine status among elderly nursing home residents in the New York City area. J Am Geriatr Soc (1993) 1.42
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology (1981) 1.40
25,26-dihydroxycholecalciferol, a metabolite of vitamin D3 with intestinal calcium transport activity. Biochemistry (1970) 1.40
Synthesis of plasmalemmal glycoproteins in intestinal epithelial cells. Separation of Golgi membranes from villus and crypt cell surface membranes; glycosyltransferase activity of surface membrane. J Cell Biol (1978) 1.39
Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med (1990) 1.39
High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int (2006) 1.39
GPI-anchored proteins associate to form microdomains during their intracellular transport in Caco-2 cells. J Cell Sci (1993) 1.36
Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol (1986) 1.35
Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab (1997) 1.34
Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med (1981) 1.33
Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med (1975) 1.33
Development of fetal rat intestine in organ and monolayer culture. J Cell Biol (1985) 1.32
The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol (1981) 1.32
The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone (2004) 1.31
Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr (1985) 1.30
Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab (1985) 1.30
Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J Clin Invest (1995) 1.30
Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun (1977) 1.30
Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol (1988) 1.30
Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med (1982) 1.29
Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc (1987) 1.29
Study of intestinal cell differentiation with monoclonal antibodies to intestinal cell surface components. Dev Biol (1985) 1.29
The isolation of metallothionein and its protective role in cadmium poisoning. Arch Biochem Biophys (1974) 1.28
Vitamin D and cancer. Anticancer Res (2006) 1.28
1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance. Pediatr Res (1975) 1.28
1,25-dihydroxycholecalciferol: metabolite of vitamin D3 active on bone in anephric rats. Science (1972) 1.26
Indian and Pakistani immigrants have the same capacity as Caucasians to produce vitamin D in response to ultraviolet irradiation. Am J Clin Nutr (1986) 1.25
An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol (2007) 1.24
Effect of I,25-dihydroxycholecalciferol in renal osteodystrophy. Can Med Assoc J (1975) 1.24
A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med (1978) 1.22
Differential localization by in situ hybridization of distinct keratin mRNA species during intestinal epithelial cell development and differentiation. Differentiation (1993) 1.21